BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 16052217)

  • 1. A model of quiescent tumour microregions for evaluating multicellular resistance to chemotherapeutic drugs.
    Mellor HR; Ferguson DJ; Callaghan R
    Br J Cancer; 2005 Aug; 93(3):302-9. PubMed ID: 16052217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implication of necrosis-linked p53 aggregation in acquired apoptotic resistance to 5-FU in MCF-7 multicellular tumour spheroids.
    Lee SY; Jeong EK; Jeon HM; Kim CH; Kang HS
    Oncol Rep; 2010 Jul; 24(1):73-9. PubMed ID: 20514446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemosensitivity of radioresistant cells in the multicellular spheroids of A549 lung adenocarcinoma.
    Shi D; Shi G; Huang G; Zhang J; Lartigau E
    J Exp Clin Cancer Res; 2009 Jun; 28(1):72. PubMed ID: 19490637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacy of novel platinum(IV) compounds with established chemotherapeutic drugs in solid tumour models.
    Hall MD; Martin C; Ferguson DJ; Phillips RM; Hambley TW; Callaghan R
    Biochem Pharmacol; 2004 Jan; 67(1):17-30. PubMed ID: 14667925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of P-glycoprotein function by XR9576 in a solid tumour model can restore anticancer drug efficacy.
    Walker J; Martin C; Callaghan R
    Eur J Cancer; 2004 Mar; 40(4):594-605. PubMed ID: 14962729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of an intrinsic P-glycoprotein-mediated doxorubicin resistance in quiescent cell layers of large, multicellular prostate tumor spheroids.
    Wartenberg M; Frey C; Diedershagen H; Ritgen J; Hescheler J; Sauer H
    Int J Cancer; 1998 Mar; 75(6):855-63. PubMed ID: 9506530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redox regulation of P-glycoprotein-mediated multidrug resistance in multicellular prostate tumor spheroids.
    Wartenberg M; Fischer K; Hescheler J; Sauer H
    Int J Cancer; 2000 Jan; 85(2):267-74. PubMed ID: 10629088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of Multicellular Tumor Spheroids with Microwell-Based Agarose Scaffolds for Drug Testing.
    Gong X; Lin C; Cheng J; Su J; Zhao H; Liu T; Wen X; Zhao P
    PLoS One; 2015; 10(6):e0130348. PubMed ID: 26090664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-nuclear localization of Ki-67 in human colorectal cancer cells grown as multicellular layers.
    Kim YJ; Lee SH; Lee J; Kuh HJ
    Arch Pharm Res; 2013 May; 36(5):634-40. PubMed ID: 23536320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The resistance of intracellular mediators to doxorubicin and cisplatin are distinct in 3D and 2D endometrial cancer.
    Chitcholtan K; Sykes PH; Evans JJ
    J Transl Med; 2012 Mar; 10():38. PubMed ID: 22394685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the spheroid model complexity on drug response.
    Hoffmann OI; Ilmberger C; Magosch S; Joka M; Jauch KW; Mayer B
    J Biotechnol; 2015 Jul; 205():14-23. PubMed ID: 25746901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of multicellular drug resistance observed in human ovarian and prostate carcinoma treated with the proteasome inhibitor PS-341.
    Frankel A; Man S; Elliott P; Adams J; Kerbel RS
    Clin Cancer Res; 2000 Sep; 6(9):3719-28. PubMed ID: 10999766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of concave microwells to pancreatic tumor spheroids enabling anticancer drug evaluation in a clinically relevant drug resistance model.
    Yeon SE; No da Y; Lee SH; Nam SW; Oh IH; Lee J; Kuh HJ
    PLoS One; 2013; 8(9):e73345. PubMed ID: 24039920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of drug exposure parameters on the activity of paclitaxel in multicellular spheroids.
    Nicholson KM; Bibby MC; Phillips RM
    Eur J Cancer; 1997 Jul; 33(8):1291-8. PubMed ID: 9301458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the cyclin-dependent kinases inhibitor p27 on resistance of ovarian cancer multicellular spheroids to anticancer chemotherapy.
    Xing H; Wang S; Hu K; Tao W; Li J; Gao Q; Yang X; Weng D; Lu Y; Ma D
    J Cancer Res Clin Oncol; 2005 Aug; 131(8):511-9. PubMed ID: 15924242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling acidosis and the cell cycle in multicellular tumour spheroids.
    Tindall MJ; Dyson L; Smallbone K; Maini PK
    J Theor Biol; 2012 Apr; 298():107-15. PubMed ID: 22155133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gel-Free 3D Tumoroids with Stem Cell Properties Modeling Drug Resistance to Cisplatin and Imatinib in Metastatic Colorectal Cancer.
    Sogawa C; Eguchi T; Namba Y; Okusha Y; Aoyama E; Ohyama K; Okamoto K
    Cells; 2021 Feb; 10(2):. PubMed ID: 33562088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced expression of EpCAM contributes to therapy resistance in esophageal adenocarcinoma.
    Sun X; Martin RCG; Zheng Q; Farmer R; Pandit H; Li X; Jacob K; Suo J; Li Y
    Cell Oncol (Dordr); 2018 Dec; 41(6):651-662. PubMed ID: 30116994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporating energy metabolism into a growth model of multicellular tumor spheroids.
    Venkatasubramanian R; Henson MA; Forbes NS
    J Theor Biol; 2006 Sep; 242(2):440-53. PubMed ID: 16650438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of agents that induce apoptosis of multicellular tumour spheroids: enrichment for mitotic inhibitors with hydrophobic properties.
    Fayad W; Rickardson L; Haglund C; Olofsson MH; D'Arcy P; Larsson R; Linder S; Fryknäs M
    Chem Biol Drug Des; 2011 Oct; 78(4):547-57. PubMed ID: 21726416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.